ROIV profile · all as-reported value updates
Roivant Sciences Ltd. (ROIV) as-reported value updates
Descriptive filing record — not investment advice. This page compares two SEC XBRL-filed values for the same fiscal period. It does not state why the values differ and is not a rating, score, or recommendation. See Disclaimer.
Reported values for the same fiscal period can differ between filings for many routine reasons: re-presentation for discontinued operations, adoption of new accounting standards, reclassifications, changes in rounding precision, and amendments. This ledger records that the filed values differ; it does not and cannot determine why. Both filings are linked below so the reader can consult the source.
Ledger table figure
| Metric | FY | Earliest XBRL-filed value | Currently on file | Difference | Difference % | Label | Filing links | Notes |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2023 | 61,280,000 | 31,530,000 | -29,750,000 | -48.55% | revised comparative figure | 0001140361-23-031798 0001140361-25-020715 | 3 filed observations examined for this concept and period. |
| Operating income | 2023 | -1,175,318,000 | -906,763,000 | 268,555,000 | +22.85% | revised comparative figure | 0001140361-23-031798 0001140361-25-020715 | 3 filed observations examined for this concept and period. |
| Operating income | 2024 | 4,242,016,000 | 4,497,032,000 | 255,016,000 | +5.67% | revised comparative figure | 0001140361-24-028145 0001635088-26-000061 | 3 filed observations examined for this concept and period. |